Parallax Volatility Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,000
Closed -$19.1M 1759
2025
Q3
$19.1M Buy
+25,000
New +$18.6M 0.03% 299
2025
Q2
Sell
-1,000
Closed -$826K 1701
2025
Q1
$826K Sell
1,000
-38,200
-97% -$31.8M ﹤0.01% 1098
2024
Q4
$30.3M Buy
39,200
+13,600
+53% +$11.3M 0.06% 257
2024
Q3
$22.7M Buy
25,600
+6,400
+33% +$5.75M 0.04% 303
2024
Q2
$17.4M Sell
19,200
-57,300
-75% -$45.8M 0.04% 325
2024
Q1
$59.5M Sell
76,500
-69,200
-47% -$49.2M 0.13% 139
2023
Q4
$84.9M Buy
145,700
+61,100
+72% +$35.7M 0.17% 104
2023
Q3
$45.4M Sell
84,600
-44,300
-34% -$22.8M 0.1% 164
2023
Q2
$60.5M Sell
128,900
-6,900
-5% -$2.89M 0.13% 132
2023
Q1
$46.6M Sell
135,800
-14,200
-9% -$4.79M 0.1% 204
2022
Q4
$54.9M Buy
150,000
+54,600
+57% +$19.4M 0.09% 256
2022
Q3
$30.8M Buy
95,400
+87,000
+1,036% +$27.6M 0.05% 408
2022
Q2
$2.72M Sell
8,400
-21,700
-72% -$6.51M ﹤0.01% 1226
2022
Q1
$8.62M Sell
30,100
-137,300
-82% -$35.3M ﹤0.01% 795
2021
Q4
$46.2M Sell
167,400
-79,300
-32% -$20.1M 0.05% 251
2021
Q3
$57M Sell
246,700
-87,100
-26% -$21.5M 0.05% 225
2021
Q2
$76.6M Buy
+333,800
New +$67.1M 0.11% 132
2021
Q1
Sell
-107,900
Closed -$18.2M 1792
2020
Q4
$18.2M Sell
107,900
-49,100
-31% -$7.33M 0.02% 554
2020
Q3
$23.2M Sell
157,000
-81,400
-34% -$12.6M 0.02% 674
2020
Q2
$39.1M Buy
238,400
+30,100
+14% +$4.62M 0.05% 321
2020
Q1
$28.9M Buy
208,300
+11,300
+6% +$1.55M 0.04% 312
2019
Q4
$25.9M Buy
197,000
+46,200
+31% +$5.36M 0.03% 354
2019
Q3
$16.9M Sell
150,800
-1,400
-0.9% -$156K 0.02% 448
2019
Q2
$16.9M Sell
152,200
-217,400
-59% -$25.6M 0.02% 402
2019
Q1
$48M Buy
369,600
+206,800
+127% +$25.1M 0.05% 164
2018
Q4
$18.8M Buy
162,800
+115,600
+245% +$12.9M 0.02% 354
2018
Q3
$5.06M Buy
+47,200
New +$4.72M 0.01% 705
2017
Q2
Sell
-7,000
Closed -$589K 3221
2017
Q1
$589K Buy
+7,000
New +$561K ﹤0.01% 1399
2016
Q4
Sell
-10,200
Closed -$819K 3696
2016
Q3
$819K Buy
+10,200
New +$816K ﹤0.01% 1325
2016
Q2
Sell
-300
Closed -$22K 3117
2016
Q1
$22K Sell
300
-266,700
-100% -$20.2M ﹤0.01% 2272
2015
Q4
$22.5M Sell
267,000
-158,200
-37% -$13.1M 0.05% 264
2015
Q3
$35.6M Buy
425,200
+395,200
+1,317% +$33.4M 0.08% 166
2015
Q2
$2.5M Buy
+30,000
New +$2.29M 0.01% 990
2015
Q1
Sell
-100,000
Closed -$6.9M 5029
2014
Q4
$6.9M Buy
100,000
+44,300
+80% +$2.99M 0.02% 592
2014
Q3
$3.61M Buy
55,700
+5,600
+11% +$355K 0.01% 855
2014
Q2
$3.12M Buy
50,100
+21,100
+73% +$1.26M 0.01% 618
2014
Q1
$1.71M Buy
29,000
+28,900
+28,900% +$1.61M 0.01% 616
2013
Q4
$5K Sell
100
-101,300
-100% -$5.07M ﹤0.01% 3118
2013
Q3
$5.1M Buy
101,400
+16,800
+20% +$880K 0.03% 364
2013
Q2
$4.16M Buy
+84,600
New +$4.6M 0.02% 446

Other funds holding LLY

Parallax Volatility Advisers's LLY Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its Eli Lilly (LLY) stake by 49% in Q1 2026, selling an estimated $3.32M and leaving 3,428 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #697.

Parallax Volatility Advisers first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. The position peaked at $56.7M in Q4 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Parallax Volatility Advisers held 3,428 shares of Eli Lilly worth $3.1M as of Q1 2026.
  • Parallax Volatility Advisers sold 3,277 Eli Lilly shares in Q1 2026, an estimated $3.32M.
  • Eli Lilly made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #697 holding.
  • Parallax Volatility Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
  • Parallax Volatility Advisers's Eli Lilly position peaked at $56.7M in Q4 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.